ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $536,205 | -21.9% | 24,905 | -2.3% | 0.02% | -22.7% |
| Q1 2024 | $686,431 | +93.0% | 25,480 | +114.7% | 0.02% | -21.4% |
| Q4 2023 | $355,744 | -32.7% | 11,870 | -54.0% | 0.03% | +40.0% |
| Q3 2023 | $528,232 | +1.9% | 25,780 | -1.2% | 0.02% | +5.3% |
| Q2 2023 | $518,349 | +9.7% | 26,087 | -5.5% | 0.02% | +18.8% |
| Q1 2023 | $472,702 | -8.2% | 27,595 | +4.8% | 0.02% | -11.1% |
| Q4 2022 | $515,082 | +22.6% | 26,320 | 0.0% | 0.02% | +12.5% |
| Q3 2022 | $420,000 | +43.3% | 26,320 | +23.6% | 0.02% | +60.0% |
| Q2 2022 | $293,000 | +31.4% | 21,290 | +51.4% | 0.01% | +42.9% |
| Q1 2022 | $223,000 | – | 14,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |